An Overview of COVID-19 and Ongoing Development of Vaccines
- 10.2991/assehr.k.220504.073How to use a DOI?
- COVID-19; Pneumonia; Vaccine development; Overview analysis; Omicron
Coronavirus disease 2019 (abbreviation: COVID-19), is an infectious disease caused by severe acute respiratory syndrome coronavirus type 2 (abbreviation: SARS-CoV-2). The first known patient of the disease was diagnosed in late 2019 in Wuhan, Hubei Province, People’s Republic of China, and the disease has since spread globally, resulting in an ongoing epidemic that has become one of the deadliest epidemics in human history. During the study of COVID-19, researchers have combined experiences in the development of SARS-CoV and MERS-CoV vaccines, given that both of them are coronavirus as well, and quickly proposed five major lines of vaccine research: inactivated vaccines, recombinant protein vaccines, viral vector vaccines, nucleic acid vaccines, and live attenuated vaccines. Emerging concepts such as reverse vaccinology and vaccinomics for vaccine design are also on experiments. This article, by means of a view study, provides an overview of the various SARS-CoV-2 vaccines currently in development and clinical trials, and the challenges people would face, such as the increased risk to be re-infected and the potential demand to develop new vaccine, in the present of the new mutant of COVID-19, Omicron.
- © 2022 The Authors. Published by Atlantis Press SARL.
- Open Access
- This is an open access article distributed under the CC BY-NC 4.0 license.
Cite this article
TY - CONF AU - Zihan Geng PY - 2022 DA - 2022/06/01 TI - An Overview of COVID-19 and Ongoing Development of Vaccines BT - Proceedings of the 2022 8th International Conference on Humanities and Social Science Research (ICHSSR 2022) PB - Atlantis Press SP - 395 EP - 398 SN - 2352-5398 UR - https://doi.org/10.2991/assehr.k.220504.073 DO - 10.2991/assehr.k.220504.073 ID - Geng2022 ER -